User menu

Influence of Chronic Nicotine Administration on Cerebral Type 1 Cannabinoid Receptor Binding : an In Vivo Micro-PET Study in the Rat Using [F-18]MK-9470

Bibliographic reference Gerard, Nathalie ; Ceccarini, Jenny ; Bormans, Guy M. ; Vanbilloen, Bert ; Casteels, Cindy ; et. al. Influence of Chronic Nicotine Administration on Cerebral Type 1 Cannabinoid Receptor Binding : an In Vivo Micro-PET Study in the Rat Using [F-18]MK-9470. In: Journal of Molecular Neuroscience, Vol. 42, no. 2, p. 162-7 (2010)
Permanent URL
  1. Balerio GN, Aso E, Berrendero F, Murtra P, Maldonado R (2004) Delta9-tetrahydrocannabinol decreases somatic and motivational manifestations of nicotine withdrawal in mice. Eur J Neurosci 20:2737–2748
  2. Breivogel CS, Walker JM, Huang SM, Roy MB, Childers SR (2004) Cannabinoid signaling in rat cerebellar granule cells: G-protein activation, inhibition of glutamate release and endogenous cannabinoids. Neuropharmacology 47:81–91
  3. Burns HD, Van Laere K, Sanabria-Bohorquez S et al (2007) [18F]MK-9470, a positron emission tomography (PET) tracer for in vivo human PET brain imaging of the cannabinoid-1 receptor. Proc Natl Acad Sci U S A 104:9800–9805
  4. Castane A, Valjent E, Ledent C, Parmentier M, Maldonado R, Valverde O (2002) Lack of CB1 cannabinoid receptors modifies nicotine behavioural responses, but not nicotine abstinence. Neuropharmacology 43:857–867
  5. Castane A, Berrendero F, Maldonado R (2005) The role of the cannabinoid system in nicotine addiction. Pharmacol Biochem Behav 81:381–386
  6. Casteels C, Vermaelen P, Nuyts J et al (2006) Construction and evaluation of multitracer small-animal PET probabilistic atlases for voxel-based functional mapping of the rat brain. J Nucl Med 47:1858–1866
  7. Casteels C, Vanbilloen B, Vercammen D et al (2010) Influence of chronic bromocriptine and levodopa administration on cerebral type 1 cannabinoid receptor binding. Synapse (in press)
  8. Cohen C., Perrault G., Voltz C., Steinberg R., Soubrié P., SR141716, a central cannabinoid (CB1) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats : , 10.1097/00008877-200209000-00018
  9. Cohen C, Kodas E, Griebel G (2005) CB1 receptor antagonists for the treatment of nicotine addiction. Pharmacol Biochem Behav 81:387–395
  10. Dani JA, Harris RA (2005) Nicotine addiction and comorbidity with alcohol abuse and mental illness. Nat Neurosci 8:1465–1470
  11. Devane WA, Dysarz FAI, Johnson MR, Melvin LS, Howlett AC (1988) Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol 34:605–613
  12. Di Marzo V, Bifulco M, De Petrocellis L (2004) The endocannabinoid system and its therapeutic exploitation. Nat Rev Drug Discov 3:771–784
  13. Goffin K, Bormans G, Casteels C et al (2008) An in vivo [18F]MK-9470 micro-PET study of type 1 cannabinoid receptor binding in Wistar rats after chronic administration of valproate and levetiracetam. Neuropharmacology 54:1103–1106
  14. Gonzalez S, Cascio MG, Fernandez-Ruiz J, Fezza F, Di Marzo V, Ramos JA (2002) Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine. Brain Res 954:73–81
  15. Govaerts SJ, Hermans E, Lambert DM (2004) Comparison of cannabinoid ligands affinities and efficacies in murine tissues and in transfected cells expressing human recombinant cannabinoid receptors. Eur J Pharm Sci 23:233–243
  16. Herkenham M, Lynn AB, Little MD et al (1990) Cannabinoid receptor localization in brain. Proc Natl Acad Sci U S A 87:1932–1936
  17. Maldonado R, Valverde O, Berrendero F (2006) Involvement of the endocannabinoid system in drug addiction. Trends Neurosci 29:225–232
  18. Marco EM, Granstrem O, Moreno E et al (2007) Subchronic nicotine exposure in adolescence induces long-term effects on hippocampal and striatal cannabinoid-CB1 and mu-opioid receptors in rats. Eur J Pharmacol 557:37–43
  19. Miksys S, Hoffmann E, Tyndale RF (2000) Regional and cellular induction of nicotine-metabolizing CYP2B1 in rat brain by chronic nicotine treatment. Biochem Pharmacol 59:1501–1511
  20. Paxinos G, Watson C (1998) The rat brain in stereotaxic coordinates. Academic, Orlando
  21. Reno LA, Zago W, Markus RP (2004) Release of [(3)H]-l-glutamate by stimulation of nicotinic acetylcholine receptors in rat cerebellar slices. Neuroscience 124:647–653
  22. Romero J, Garcia L, Fernandez-Ruiz JJ, Cebeira M, Ramos JA (1995) Changes in rat brain cannabinoid binding sites after acute or chronic exposure to their endogenous agonist, anandamide, or to delta 9-tetrahydrocannabinol. Pharmacol Biochem Behav 51:731–737
  23. Rose JE, Behm FM, Salley AN et al (2007) Regional brain activity correlates of nicotine dependence. Neuropsychopharmacology 32:2441–2452
  24. Sanabria-Bohórquez SM, Hamill TG, Goffin K et al (2010) Kinetic analysis of the cannabinoid-1 receptor PET Tracer [18F]MK-9470 in human brain. Eur J Nucl Med Mol Imaging (in press)
  25. Sim-Selley LJ, Martin BR (2002) Effect of chronic administration of R-(+)-[2,3-dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1, 2, 3-de]-1, 4-b enzoxazinyl]-(1-naphthalenyl)methanone mesylate (WIN55, 212–2) or delta(9)-tetrahydrocannabinol on cannabinoid receptor adaptation in mice. J Pharmacol Exp Ther 303:36–44
  26. Siu EC, Tyndale RF (2007) Non-nicotinic therapies for smoking cessation. Annu Rev Pharmacol Toxicol 47:541–564
  27. Terry GE, Liow JS, Zoghbi SS et al (2009) Quantitation of cannabinoid CB1 receptors in healthy human brain using positron emission tomography and an inverse agonist radioligand. Neuroimage 48:362–370
  28. Valjent E, Mitchell JM, Besson MJ, Caboche J, Maldonado R (2002) Behavioural and biochemical evidence for interactions between delta 9-tetrahydrocannabinol and nicotine. Br J Pharmacol 135:564–578
  29. Van Laere K, Goffin K, Casteels C et al (2008) Gender-dependent increases with healthy aging of the human cerebral cannabinoid-type 1 receptor binding using [(18)F]MK-9470 PET. Neuroimage 39:1533–1541
  30. Viveros MP, Marco EM, File SE (2006) Nicotine and cannabinoids: parallels, contrasts and interactions. Neurosci Biobehav Rev 30:1161–1181
  31. Werling LL, Reed SC, Wade D, Izenwasser S (2009) Chronic nicotine alters cannabinoid-mediated locomotor activity and receptor density in periadolescent but not adult male rats. Int J Dev Neurosci 27:263–269